Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: A new entity within the spectrum of autoinflammatory syndromes?

Journal of the European Academy of Dermatology and Venereology

Volumn 30, Issue 1, 2016, Pages 141-143

  Garzorz, N ^a   Papanagiotou, V ^a   Atenhan, A ^b   Andres, C ^a   Eyerich, S ^b   Eyerich, K ^a   Ring, J ^a   Brockow, K ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 17; TUMOR NECROSIS FACTOR;

ACNE; ACNE VULGARIS; ADULT; ARTHRALGIA; ARTHRITIS; AUTOINFLAMMATORY DISEASE; BACKACHE; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; FEMALE; GENETIC ANALYSIS; HAND JOINT; HISTOLOGY; HUMAN; LETTER; PAPA SYNDROME; PAPASH SYNDROME; PRIORITY JOURNAL; PSORIASIS; PYODERMA GANGRENOSUM; SKIN BIOPSY; SUPPURATIVE HIDRADENITIS; SYNDROME; ANTAGONISTS AND INHIBITORS; COMBINATION DRUG THERAPY; HIDRADENITIS SUPPURATIVA;

ACNE VULGARIS; ADULT; ARTHRITIS; DRUG THERAPY, COMBINATION; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; INTERLEUKIN-17; PSORIASIS; PYODERMA GANGRENOSUM; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84955178361     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12631     Document Type: Letter

References (10)

1. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T,. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)- A new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2012; 66: 409-415.
2. Smith EJ, Allantaz F, Bennett L, et al,. Clinical, molecular, and genetic characteristics of PAPA syndrome: a review. Curr Genomics 2010; 11: 519-527.
3. Bruzzese V,. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor alpha therapy. J Clin Rheumatol 2012; 18: 413-415.
4. Rivas Bejarano JJ, Valdecantos WC,. Psoriasis as autoinflammatory disease. Dermatol Clin 2013; 31: 445-460.
5. Martin DA, Towne JE, Kricorian G, et al,. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol 2013; 133: 17-26.
6. Agak GW, Qin M, Nobe J, et al,. Propionibacterium acnes Induces an IL-17 Response in Acne Vulgaris that Is Regulated by Vitamin A and Vitamin D. J Invest Dermatol 2014; 134: 366-373.
7. Schlapbach C, Hanni T, Yawalkar N, Hunger RE,. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 2011; 65: 790-798.
8. Patel DD, Lee DM, Kolbinger F, Antoni C,. Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 2013; 72 (Suppl. 2): ii116-ii123.
9. Marzano AV, Cugno M, Trevisan V, et al,. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010; 162: 100-107.
10. Fischer-Stabauer M, Boehner A, Eyerich S, et al,. Differential in situ expression of IL-17 in skin diseases. Eur J Dermatol 2012; 22: 781-784.